Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer.
Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer. Breast Cancer Res Treat. 2010 Dec; 124(3):857-61.